Could the mechanisms of bariatric surgery hold the key for novel therapies?: Report from a Pennington Scientific Symposium

Obesity Reviews

Volumn 12, Issue 11, 2011, Pages 984-994

  Tam, C S ^a   Berthoud, H R ^a   Bueter, M ^b   Chakravarthy, M V ^c   Geliebter, A ^d   Hajnal, A ^e   Holst, J ^f   Kaplan, L ^g   Pories, W ^h   Raybould, H ⁱ   Seeley, R ^j   Strader, A ^k   Ravussin, E ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c MERCK RESEARCH LABORATORIES   (United States)

^d Columbia University ^*  (United States)

^e PENN STATE COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h EAST CAROLINA UNIVERSITY   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY OF CINCINNATI   (United States)

^k SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Bariatric surgery; Gut hormones; Weight loss

Indexed keywords

CHOLECYSTOKININ A RECEPTOR; GASTRIC INHIBITORY POLYPEPTIDE; GASTROINTESTINAL HORMONE; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 2; PEPTIDE YY [3-36];

ARTICLE; BARIATRIC SURGERY; CALORIC INTAKE; DIABETES MELLITUS; DIABETIC OBESITY; ENERGY BALANCE; ENERGY METABOLISM; FOOD INTAKE; GASTRIC BANDING; GASTROINTESTINAL TRACT FUNCTION; HUMAN; MORBID OBESITY; MORTALITY; NONHUMAN; SYSTEMATIC REVIEW; WEIGHT REDUCTION;

BARIATRIC SURGERY; ENERGY METABOLISM; GHRELIN; GLUCAGON-LIKE PEPTIDE 1; HUMANS; OBESITY, MORBID; PEPTIDE YY; WEIGHT LOSS;

EID: 80054844912     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/j.1467-789X.2011.00902.x     Document Type: Article

References (50)

1. Schwartz A, Doucet E. Relative changes in resting energy expenditure during weight loss: a systematic review. Obes Rev 2010; 11: 531-547.
2. Bobbioni-Harsch E, Morel P, Huber O, Assimacopoulos-Jeannet F, Chassot G, Lehmann T etal. Energy economy hampers body weight loss after gastric bypass. J Clin Endocrinol Metab 2000; 85: 4695-4700.
3. Carrasco F, Papapietro K, Csendes A, Salazar G, Echenique C, Lisboa C etal. Changes in resting energy expenditure and body composition after weight loss following Roux-en-Y gastric bypass. Obes Surg 2007; 17: 608-616.
4. van Gemert WG, Westerterp KR, van Acker BA, Wagenmakers AJ, Halliday D, Greve JM etal. Energy, substrate and protein metabolism in morbid obesity before, during and after massive weight loss. Int J Obes Relat Metab Disord 2000; 24: 711-718.
5. Ding S, Chi MM, Scull BP, Rigby R, Schwerbrock NM, Magness S etal. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS ONE 2010; 5: e12191.
6. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D etal. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56: 1761-1772.
7. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM etal. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008; 57: 1470-1481.
8. de La Serre CB, Ellis CL, Lee J, Hartman AL, Rutledge JC, Raybould HE. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol 2010; 299: G440-G448.
9. Korner J, Bessler M, Inabnet W, Taveras C, Holst JJ. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg Obes Relat Dis 2007; 3: 597-601.
10. Isbell JM, Tamboli RA, Hansen EN, Saliba J, Dunn JP, Phillips SE etal. The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery. Diabetes Care 2010; 33: 1438-1442.
11. Miholic J, Orskov C, Holst JJ, Kotzerke J, Meyer HJ. Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy. Dig Dis Sci 1991; 36: 1361-1370.
12. Layer P, Holst JJ, Grandt D, Goebell H. Ileal release of glucagon-like peptide-1 (GLP-1). Association with inhibition of gastric acid secretion in humans. Dig Dis Sci 1995; 40: 1074-1082.
13. McLaughlin T, Peck M, Holst J, Deacon C. Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery. J Clin Endocrinol Metab 2010; 95: 1851-1855.
14. Dirksen C, Hansen DL, Madsbad S, Hvolris LE, Naver LS, Holst JJ etal. Postprandial diabetic glucose tolerance is normalized by gastric bypass feeding as opposed to gastric feeding and is associated with exaggerated GLP-1 secretion: a case report. Diabetes Care 2010; 33: 375-377.
15. Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev 2007; 87: 1409-1439.
16. Nauck MA, Kleine N, Orskov C, Holst JJ, Willms B, Creutzfeldt W. Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1993; 36: 741-744.
17. Rachman J, Barrow BA, Levy JC, Turner RC. Near-normalisation of diurnal glucose concentrations by continuous administration of glucagon-like peptide-1 (GLP-1) in subjects with NIDDM. Diabetologia 1997; 40: 205-211.
18. Verdich C, Flint A, Gutzwiller JP, Naslund E, Beglinger C, Hellstrom PM etal. A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. J Clin Endocrinol Metab 2001; 86: 4382-4389.
19. Schmidt WE. Early clinical studies with liraglutide. Int J Clin Pract Suppl 2010; 64: 12-20.
20. Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H etal. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357: 741-752.
21. Christou NV, Sampalis JS, Liberman M, Look D, Auger S, McLean AP etal. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 2004; 240: 416-423.
22. Maggard MA, Shugarman LR, Suttorp M, Maglione M, Sugerman HJ, Livingston EH etal. Meta-analysis: surgical treatment of obesity. Ann Intern Med 2005; 142: 547-559.
23. Makary MA, Clarke JM, Shore AD, Magnuson TH, Richards T, Bass EB etal. Medication utilization and annual health care costs in patients with type 2 diabetes mellitus before and after bariatric surgery. Arch Surg 2010; 145: 726-731.
24. Stylopoulos N, Hoppin AG, Kaplan LM. Roux-en-Y gastric bypass enhances energy expenditure and extends lifespan in diet-induced obese rats. Obesity (Silver Spring) 2009; 17: 1839-1847.
25. Aguirre V, Stylopoulos N, Grinbaum R, Kaplan LM. An endoluminal sleeve induces substantial weight loss and normalizes glucose homeostasis in rats with diet-induced obesity. Obesity (Silver Spring) 2008; 16: 2585-2592.
26. Bueter M, Lowenstein C, Ashrafian H, Hillebrand J, Bloom SR, Olbers T etal. Vagal sparing surgical technique but not stoma size affects body weight loss in rodent model of gastric bypass. Obes Surg 2010; 20: 616-622.
27. Bueter M, Lowenstein C, Olbers T, Wang M, Cluny NL, Bloom SR etal. Gastric bypass increases energy expenditure in rats. Gastroenterology 2010; 138: 1845-1853.
28. Olbers T, Bjorkman S, Lindroos A, Maleckas A, Lonn L, Sjostrom L etal. Body composition, dietary intake, and energy expenditure after laparoscopic Roux-en-Y gastric bypass and laparoscopic vertical banded gastroplasty: a randomized clinical trial. Ann Surg 2006; 244: 715-722.
29. Hajnal A, Kovacs P, Ahmed T, Meirelles K, Lynch CJ, Cooney RN. Gastric bypass surgery alters behavioral and neural taste functions for sweet taste in obese rats. Am J Physiol Gastrointest Liver Physiol 2010; 299: G967-G979.
30. Zheng H, Shin AC, Lenard NR, Townsend RL, Patterson LM, Sigalet DL etal. Meal patterns, satiety, and food choice in a rat model of Roux-en-Y gastric bypass surgery. Am J Physiol Regul Integr Comp Physiol 2009; 297: R1273-R1282.
31. le Roux CW, Welbourn R, Werling M, Osborne A, Kokkinos A, Laurenius A etal. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg 2007; 246: 780-785.
32. le Roux CW, Aylwin SJ, Batterham RL, Borg CM, Coyle F, Prasad V etal. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 2006; 243: 108-114.
33. Shin AC, Zheng H, Townsend RL, Sigalet DL, Berthoud HR. Meal-induced hormone responses in a rat model of Rouxen-Y gastric bypass surgery. Endocrinology 2010; 151: 1588-1597.
34. Trevaskis JL, Parkes DG, Roth JD. Insights into amylin-leptin synergy. Trends Endocrinol Metab 2010; 21: 473-479.
35. Roth JD, Roland BL, Cole RL, Trevaskis JL, Weyer C, Koda JE etal. Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies. Proc Natl Acad Sci USA 2008; 105: 7257-7262.
36. Ravussin E, Smith SR, Mitchell JA, Shringarpure R, Shan K, Maier H etal. Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy. Obesity (Silver Spring) 2009; 17: 1736-1743.
37. Strader AD, Clausen TR, Goodin SZ, Wendt D. Ileal interposition improves glucose tolerance in low dose streptozotocin-treated diabetic and euglycemic rats. Obes Surg 2009; 19: 96-104.
38. Strader AD, Vahl TP, Jandacek RJ, Woods SC, D'Alessio DA, Seeley RJ. Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. Am J Physiol Endocrinol Metab 2005; 288: E447-E453.
39. Cummings BP, Strader AD, Stanhope KL, Graham JL, Lee J, Raybould HE etal. Ileal interposition surgery improves glucose and lipid metabolism and delays diabetes onset in the UCD-T2DM rat. Gastroenterology 2010; 138: 2437-2446.
40. Manfredini G, Ermini M, Scopsi L, Bonaguidi F, Ferrannini E. Internal biliary diversion improves glucose tolerance in the rat. Am J Physiol 1985; 249: G519-G527.
41. Ermini M, Iaconis E, Mori A. The effects of bilio-jejunal diversion on streptozotocin diabetes in the rat. Acta Diabetol Lat 1991; 28: 79-89.
42. Stefater MA, Perez-Tilve D, Chambers AP, Wilson-Perez HE, Sandoval DA, Berger J etal. Sleeve gastrectomy induces loss of weight and fat mass in obese rats, but does not affect leptin sensitivity. Gastroenterology 2010; 138: 2426-2436.
43. Kohli R, Kirby M, Setchell KD, Jha P, Klustaitis K, Woollett LA etal. Intestinal adaptation after ileal interposition surgery increases bile acid recycling and protects against obesity-related comorbidities. Am J Physiol Gastrointest Liver Physiol 2010; 299: G652-G660.
44. Hajnal A, Covasa M, Bello NT. Altered taste sensitivity in obese, prediabetic OLETF rats lacking CCK-1 receptors. Am J Physiol Regul Integr Comp Physiol 2005; 289: R1675-R1686.
45. Geliebter A, Westreich S, Gage D. Gastric distention by balloon and test-meal intake in obese and lean subjects. Am J Clin Nutr 1988; 48: 592-594.
46. Geliebter A. Gastric distension and gastric capacity in relation to food intake in humans. Physiol Behav 1988; 44: 665-668.
47. Wang GJ, Tomasi D, Backus W, Wang R, Telang F, Geliebter A etal. Gastric distention activates satiety circuitry in the human brain. Neuroimage 2008; 39: 1824-1831.
48. Geliebter A, Ladell T, Logan M, Schneider T, Sharafi M, Hirsch J. Responsivity to food stimuli in obese and lean binge eaters using functional MRI. Appetite 2006; 46: 31-35.
49. Ochner CN, Kwok Y, Conceicao E, Pantazatos SP, Puma LM, Carnell S etal. Selective reduction in neural responses to high calorie foods following gastric bypass surgery. Ann Surg 2011; 253: 502-507.
50. Ochner CN, Gibson C, Carnell S, Dambkowski C, Geliebter A. The neurohormonal regulation of energy intake in relation to bariatric surgery for obesity. Physiol Behav 2010; 100: 549-559.